Page last updated: 2024-08-18

4-butyrolactone and myelin oligodendrocyte glycoprotein (35-55)

4-butyrolactone has been researched along with myelin oligodendrocyte glycoprotein (35-55) in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Flaherty, S; Reynolds, JM; Sharma-Walia, N; Woodman, KM; Young, KE1

Other Studies

1 other study(ies) available for 4-butyrolactone and myelin oligodendrocyte glycoprotein (35-55)

ArticleYear
Fatty acid synthase regulates the pathogenicity of Th17 cells.
    Journal of leukocyte biology, 2017, Volume: 102, Issue:5

    Topics: 4-Butyrolactone; Animals; Cell Differentiation; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Fatty Acid Synthase, Type I; Gene Expression Regulation; Humans; Interferon-gamma; Interleukin-17; Interleukin-23; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Knockout; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Primary Cell Culture; Signal Transduction; T-Lymphocytes, Regulatory; Th1 Cells; Th17 Cells; Toll-Like Receptor 2

2017